[Home ] [Archive]    
:: Main :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
Indexing Sources::
For Authors::
Publication ethics::
Registration::
Contact us::
Site Facilities::
::
Creative Commons License
AWT IMAGE

This Journal under a

Creative Commons Attribution-NonCommercial 4.0 International License.

..
Open Access Policy

AWT IMAGE

..
cope

AWT IMAGE

..
Registered in

AWT IMAGE

AWT IMAGE

..
:: Volume 8, Issue 1 (Jan-Mar 2021) ::
Nutr Food Sci Res 2021, 8(1): 1-3 Back to browse issues page
Can Raising Vitamin D Status Slow Down Covid-19 Waves?
Vahid Ranaei , Zahra Pilevar , Tirang R Neyestani *
Laboratory of Nutrition Research, National Nutrition and Food Technology Research Institute and Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran , t.neyestani@sbmu.ac.ir
Abstract:   (2516 Views)
Several mitigation and suppression policies, such as social distancing, city lockdowns, remote working, testing, providing personal protective equipment and health care resource availability have been implemented by the governments in response to Covid-19 pandemic. Until now (October 23, 2020), over 1.14 million deaths in the world including 31,650 just in Iran have been officially attributed to this newly emerged viral disease (1). There is an enormous variation in the clinical symptoms of Covid-19, ranging from a mild common cold to severe symptoms such as acute respiratory distress syndrome (ARDS) and septic shock. Several factors may influence the severity of Covid-19 disease such as co-infection, co-morbidities, genetic and host factors including race, age, and obesity (2). Currently, there is no effective drug or vaccine available to treat or prevent the disease.
Keywords: Covid-19, vitamin D deficiency, Iran
Full-Text [PDF 283 kb]   (935 Downloads)    
Article type: Editorial | Subject: Nutrition
Received: 2020/11/10 | Accepted: 2020/12/8 | Published: 2021/01/3
References
1. Saunders MJ, Evans CA. COVID-19, tuberculosis, and poverty: preventing a perfect storm. Eur Respir J. 2020. [DOI:10.1183/13993003.01348-2020]
2. Zhang X, Tan Y, Ling Y, Lu G, Liu F, Yi Z, et al. Viral and host factors related to the clinical outcome of COVID-19. Nature. 2020;583(7816):437-40. [DOI:10.1038/s41586-020-2355-0]
3. Khan Z, Karataş Y, Rahman H. Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action. Advances in therapy. 2020:1. [DOI:10.1007/s12325-020-01351-9]
4. Kaur SP, Gupta V. COVID-19 Vaccine: A comprehensive status report. Virus research. 2020:198114. [DOI:10.1016/j.virusres.2020.198114]
5. Roth DE, Abrams SA, Aloia J, Bergeron G, Bourassa MW, Brown KH, et al. Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low-and middle-income countries. 2018.
6. Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? The Journal of steroid biochemistry and molecular biology. 2014;144:138-45. [DOI:10.1016/j.jsbmb.2013.11.003]
7. Neyestani TR, Hajifaraji M, Omidvar N, Eshraghian MR, Shariatzadeh N, Kalayi A, et al. High prevalence of vitamin D deficiency in school-age children in Tehran, 2008: a red alert. Public Health Nutr. 2012;15(2):324-30. [DOI:10.1017/S1368980011000188]
8. Nikooyeh B, Abdollahi Z, Hajifaraji M, Alavi-Majd H, Salehi F, Yarparvar AH, et al. Vitamin D status and cardiometabolic risk factors across latitudinal gradient in Iranian adults. Nutr Health. 2017:260106017702918. [DOI:10.1177/0260106017702918]
9. Nikooyeh B, Abdollahi Z, Hajifaraji M, Alavi-Majd H, Salehi F, Yarparvar AH, et al. Vitamin D Status, Latitude and their Associations with Some Health Parameters in Children: National Food and Nutrition Surveillance. J Trop Pediatr. 2017;63(1):57-64. [DOI:10.1093/tropej/fmw057]
10. Nikooyeh B, Abdollahi Z, Hajifaraji M, Alavi-Majd H, Salehi F, Yarparvar AH, et al. Healthy changes in some cardiometabolic risk factors accompany the higher summertime serum 25-hydroxyvitamin D concentrations in Iranian children: National Food and Nutrition Surveillance. Public Health Nutr. 2018;21(11):2013-21. [DOI:10.1017/S1368980018000630]
11. Nikooyeh B, Neyestani TR. Poor vitamin D status increases the risk of anemia in school children: National Food and Nutrition Surveillance. Nutrition. 2018;47:69-74. [DOI:10.1016/j.nut.2017.09.008]
12. Wang TJ, Zhang F, Richards JB, Kestenbaum B, Van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. The Lancet. 2010;376(9736):180-8. [DOI:10.1016/S0140-6736(10)60588-0]
13. Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Köstenberger M, Berisha AT, et al. Vitamin D deficiency 2.0: An update on the current status worldwide. Eur J Clin Nutr. 2020:1-16. [DOI:10.1038/s41430-020-0558-y]
14. Nikooyeh B, Neyestani TR, ALAVI MH, Kalayi A, Shariatzadeh N, Zahedirad M, et al. Vitamin D deficiency is associated with the metabolic syndrome in subjects with type 2 diabetes. 2014.
15. Salekzamani S, Neyestani TR, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, et al. Is vitamin D status a determining factor for metabolic syndrome? A case-control study. Diabetes, metabolic syndrome and obesity: targets and therapy. 2011;4:205. [DOI:10.2147/DMSO.S21061]
16. Hastie CE, Mackay DF, Ho F, Celis-Morales CA, Katikireddi SV, Niedzwiedz CL, et al. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020. [DOI:10.1016/j.dsx.2020.04.050]
17. Sassi F, Tamone C, D'Amelio P. Vitamin D: Nutrient, Hormone, and Immunomodulator. 2018;10(11). [DOI:10.3390/nu10111656]
18. Bilezikian JP, Bikle D, Hewison M, Lazaretti-Castro M, Formenti AM, Gupta A, et al. Mechanisms in endocrinology: Vitamin D and COVID-19. European journal of endocrinology. 2020;183(5):R133-R47. [DOI:10.1530/EJE-20-0665]
19. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1, 25‐dihydroxyvitamin D3. The FASEB journal. 2005;19(9):1067-77. [DOI:10.1096/fj.04-3284com]
20. Gruber-Bzura BM. Vitamin D and influenza-prevention or therapy? Int J Mol Sci. 2018;19(8):2419. [DOI:10.3390/ijms19082419]
21. McCartney DM, Byrne D. Optimisation of vitamin D status for enhanced Immuno-protection against Covid-19. Ir Med J. 2020;113(4):58.
22. Telcian AG, Zdrenghea MT, Edwards MR, Laza-Stanca V, Mallia P, Johnston SL, et al. Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro. Antiviral Res. 2017;137:93-101. [DOI:10.1016/j.antiviral.2016.11.004]
23. Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. J Clin Virol. 2011;50(3):194-200. [DOI:10.1016/j.jcv.2010.12.006]
24. Park S, Lee MG, Hong S-B, Lim C-M, Koh Y, Huh JW. Effect of vitamin D deficiency in Korean patients with acute respiratory distress syndrome. The Korean journal of internal medicine. 2018;33(6):1129. [DOI:10.3904/kjim.2017.380]
25. Zhou Y-F, Luo B-A, Qin L-L. The association between vitamin D deficiency and community-acquired pneumonia: A meta-analysis of observational studies. Medicine. 2019;98(38). [DOI:10.1097/MD.0000000000017252]
26. D'Avolio A, Avataneo V, Manca A, Cusato J, De Nicolò A, Lucchini R, et al. 25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients. 2020;12(5):1359. [DOI:10.3390/nu12051359]
27. Grant WB, Giovannucci E. The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918-1919 influenza pandemic in the United States. Dermatoendocrinol. 2009;1(4):215-9. [DOI:10.4161/derm.1.4.9063]
28. Vankadari N, Wilce JA. Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerging microbes & infections. 2020;9(1):601-4. [DOI:10.1080/22221751.2020.1739565]
29. Komolmit P, Charoensuk K, Thanapirom K, Suksawatamnuay S, Thaimai P, Chirathaworn C, et al. Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial. PLoS One. 2017;12(4):e0174608. [DOI:10.1371/journal.pone.0174608]
30. Neyestani TR, Hajifaraji M, Omidvar N, Eshraghian MR, Shariatzadeh N, Kalayi A, et al. High prevalence of vitamin D deficiency in school-age children in Tehran, 2008: a red alert. Public Health Nutr. 2012;15(02):324-30. [DOI:10.1017/S1368980011000188]
31. Guide for vitamin D supplementation to enhance immunity against coronavirus infection. National Food and Nutririton Surveillance. National Nutrition and Food Technology Research Institute.
32. http://www.nfns.ir/blog/%D8%A8%DB%8C%D9%85%D8%A7%D8%B1%DB%8C-%DA%A9%D9%88%D9%88%DB%8C%D8%AF-19/item/142-coronavirus-and-vitamin-d.html 2020.
33. Neyestani T, Hajifaraji M, Omidvar N, Nikooyeh B, Eshraghian M, Shariatzadeh N, et al. Calcium‐vitamin D‐fortified milk is as effective on circulating bone biomarkers as fortified juice and supplement but has less acceptance: a randomised controlled school‐based trial. J Hum Nutr Diet. 2014;27(6):606-16. [DOI:10.1111/jhn.12191]
34. Nikooyeh B, Zargaraan A, Kalayi A, Shariatzadeh N, Zahedirad M, Jamali A, et al. Vitamin D-fortified cooking oil is an effective way to improve vitamin D status: an institutional efficacy trial. Eur J Nutr. 2019:1-9. [DOI:10.1007/s00394-019-02103-4]
35. Nikpouraghdam M, Farahani AJ, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. J Clin Virol. 2020. [DOI:10.1016/j.jcv.2020.104378]
36. Alamdari NM, Afaghi S, Rahimi FS, Tarki FE, Tavana S, Zali A, et al. Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran. The Tohoku Journal of Experimental Medicine. 2020;252(1):73-84. [DOI:10.1620/tjem.252.73]
37. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988. [DOI:10.3390/nu12040988]
38. Tapper J. Add vitamin D to bread and milk to help fight Covid, urge scientists. The Gaurdian (https://wwwtheguardiancom/world/2020/oct/31/add-vitamin-d-bread-milk-help-fight-covid-urge-scientists-deficiency-supplements). 2020.
39. Ali N. Role of vitamin D in preventing of COVID-19 infection, progression and severity. Journal of infection and public health. 2020. 1373-1380 [DOI:10.1016/j.jiph.2020.06.021]
40. Kimball S, Mirhosseini N, Holick M. Evaluation of vitamin D3 intakes up to 15,000 international units/day and serum 25-hydroxyvitamin D concentrations up to 300 nmol/L on calcium metabolism in a community setting. Dermatoendocrinol. 2017;9(1):e1300213. [DOI:10.1080/19381980.2017.1300213]
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ranaei V, Pilevar Z, Neyestani T R. Can Raising Vitamin D Status Slow Down Covid-19 Waves?. Nutr Food Sci Res 2021; 8 (1) :1-3
URL: http://nfsr.sbmu.ac.ir/article-1-467-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 8, Issue 1 (Jan-Mar 2021) Back to browse issues page
Nutrition and Food Sciences Research
Persian site map - English site map - Created in 0.06 seconds with 45 queries by YEKTAWEB 4660